LactoRing® — vaginal ring for the treatment of bacterial vaginosis, now for the first time in Ukraine

Aiсore Life Sciences has developed, for the first time in the world, an original, innovative medical device in the form of a vaginal ring for round-the-clock treatment and prevention of bacterial vaginosis — LactoRing®. The product is manufactured in the Netherlands and is already available in pharmacy networks.

The unique delivery form of LactoRing® — a vaginal ring containing 150 mg of lactic acid — allows for stable release of the active ingredient throughout the one week of use.

Lactic acid inhibits the growth of pathogenic bacteria but does not affect the normal microflora, making LactoRing® a physiologically justified choice for supporting women’s health.

LactoRing® is recommended:
– to relieve symptoms of bacterial vaginosis such as itching, burning, unpleasant odor, and excessive discharge;
– as part of combination therapy, complementing antibacterial medications;
– for the prevention of bacterial vaginosis recurrence;
– to normalize pH after a course of antibiotics.

Bacterial vaginosis is a quite common pathogenic condition, experienced by over 30% of women worldwide during their lifetime. The disease not only causes significant discomfort but is also associated with a number of potentially serious complications. The main cause of bacterial vaginosis is a pH imbalance, which leads to displacement of the normal microflora by pathogenic bacteria. LactoRing® is an innovative solution to the problem of bacterial vaginosis.

The vaginal ring LactoRing® is designed to provide maximum efficacy combined with a convenient usage regimen.